Abstract:BACKGROUND:Tumor micronecrosis is a less investigated pathological feature of hepatocellular carcinoma (HCC). This study was aimed at evaluating the value of micronecrosis for guiding adjuvant transcatheter arterial chemoembolization (TACE) in HCC management. METHODS:We retrospectively reviewed the data of patients with HCC who underwent curative liver resection in our center from 2014 to 2018. The patients were divided into micronecrosis (+) and micronecrosis (-) groups. In each group, overall survival (OS) and disease-free survival (DFS) were compared between patients who underwent adjuvant TACE and those who did not. Propensity score matching (PSM) was conducted at a ratio of 1:1 to control selection bias. Univariate and multivariate analyses were performed to determine independent prognostic factors. Mass cytometry was applied to compare the immunological status of HCCs between the two groups. RESULTS:A total of 897 patients were included, with 417 and 480 patients in the micronecrosis (+) and micronecrosis (-) groups, respectively. No significant difference was detected in baseline parameters after PSM. In the micronecrosis (+) group, patients who underwent adjuvant TACE had significant longer OS than did those who did not (P = 0.004). However, patients in the micronecrosis (-) group did not benefit from adjuvant TACE. Although adjuvant TACE prolonged the DFS of patients with severe micronecrosis (P = 0.034), it may adversely affect the DFS of patients without micronecrosis (P = 0.131). Multivariate analysis showed that TACE was an independent prognostic factor for patients with micronecrosis but not for those without micronecrosis. The abundance of exhausted and regulatory T cells was significantly higher in patients with micronecrosis. CONCLUSIONS:For HCC patients with micronecrosis, adjuvant TACE after curative resection could improve the prognosis, while its survival benefits were limited in HCC patients without micronecrosis. TACE should be selectively performed in patients with micronecrosis, especially those with an Nscore = 2. The immunosuppressive status of HCC patients with micronecrosis may explain the effectiveness of adjuvant TACE in such scinario.

The Influence of Peritumoral Parenchyma on Local Tumor Progression of Hepatocellular Carcinoma after Thermal Ablation: a Retrospective Multicenter Study

Are All Local Tumour Progressions of HCC Related to Thermal Ablation? A Study of the Causes and Classification of Local Tumour Progression.

Comparison of Parallel and Crossed Placement of Antennas in Microwave Ablation of 3–5 Cm Hepatocellular Carcinoma

Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular Carcinoma

The Effect of Tumor Location on Long-Term Results of Microwave Ablation for Early-Stage Hepatocellular Carcinoma.

Intratumoral Perfusion May Affect Microwave Ablation Area of Hepatocellular Carcinoma

Local Tumor Progression After Ultrasound-Guided Percutaneous Microwave Ablation Of Stage T1a Renal Cell Carcinoma: Risk Factors Analysis Of 171 Tumors

Prognostic value of preoperative absolute lymphocyte count in recurrent hepatocellular carcinoma following thermal ablation: a retrospective analysis.

Laparoscopic resection vs thermal ablation for 3-5cm hepatocellular carcinoma: A multicenter study based on machine learning

Local Tumour Progression after Ultrasound-Guided Microwave Ablation of Liver Malignancies: Risk Factors Analysis of 2529 Tumours.

Long-term Outcome of Percutaneous Radiofrequency Ablation for Periportal Hepatocellular Carcinoma: Tumor Recurrence or Progression, Survival and Clinical Significance

Percutaneous Thermal Ablation of Medium and Large Hepatocellular Carcinoma: Long-term Outcome and Prognostic Factors

Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables

Comparing Long-Term Survival Benefits of Hepatocellular Carcinoma between Thermal Ablation Monotherapy and Combined Therapy with Transarterial Chemoembolization: A Propensity Score Matched Study

[Spatial distribution pattern of local tumor progression analysis after microwave ablation of hepatocellular carcinoma based on three-dimensional magnetic resonance imaging]

Mid-term Outcome of Percutaneous Thermal Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Percutaneous Thermal Ablation for the Treatment of Colorectal Liver Metastases and Hepatocellular Carcinoma: a Comparison of Local Therapeutic Efficacy

Comparison of anatomical thermal ablation and routine thermal ablation for hepatocellular carcinoma <= 50 mm: A propensity score matching

Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.

Analysis of risk factors for local tumor progression after radiofrequency ablation of hepatocellular carcinoma

Correlation of Needle Biopsy-Acquired Histopathologic Grade of Hepatocellular Carcinoma with Outcomes after Thermal Ablation